MX9100357A - Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion - Google Patents

Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion

Info

Publication number
MX9100357A
MX9100357A MX9100357A MX9100357A MX9100357A MX 9100357 A MX9100357 A MX 9100357A MX 9100357 A MX9100357 A MX 9100357A MX 9100357 A MX9100357 A MX 9100357A MX 9100357 A MX9100357 A MX 9100357A
Authority
MX
Mexico
Prior art keywords
procedure
preparation
pharmaceutical compositions
stabilized pharmaceutical
stabilized
Prior art date
Application number
MX9100357A
Other languages
English (en)
Inventor
Bruce Allan Rose
Richard Victor Vivilecchia
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of MX9100357A publication Critical patent/MX9100357A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9100357A 1990-07-25 1991-07-24 Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion MX9100357A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (1)

Publication Number Publication Date
MX9100357A true MX9100357A (es) 1992-02-28

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9100357A MX9100357A (es) 1990-07-25 1991-07-24 Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion

Country Status (30)

Country Link
EP (1) EP0468929B1 (es)
JP (1) JP2502849B2 (es)
KR (1) KR100227156B1 (es)
AT (1) AT400519B (es)
AU (1) AU639354B2 (es)
CA (1) CA2047802C (es)
CH (1) CH683150A5 (es)
CZ (1) CZ280184B6 (es)
DE (1) DE4124409B4 (es)
DK (1) DK0468929T3 (es)
ES (1) ES2061218T3 (es)
FI (1) FI98127C (es)
GB (1) GB2246296B (es)
HU (1) HU222489B1 (es)
IE (1) IE66184B1 (es)
IL (1) IL98934A (es)
IT (1) IT1290797B1 (es)
LU (1) LU87980A1 (es)
MX (1) MX9100357A (es)
MY (1) MY107183A (es)
NO (1) NO912872D0 (es)
NZ (1) NZ239078A (es)
PL (1) PL167712B1 (es)
PT (1) PT98417B (es)
RU (1) RU2075310C1 (es)
SA (1) SA92130106B1 (es)
SK (1) SK278563B6 (es)
TW (1) TW212757B (es)
UA (1) UA26064A1 (es)
ZA (1) ZA915861B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0719280B1 (en) * 1994-07-13 1999-11-10 Lek, Tovarna Farmacevtskih in Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
JP3727848B2 (ja) 1998-06-05 2005-12-21 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 酸化マグネシウムを使用する、ace阻害剤を含有する組成物の安定化
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
EA007981B1 (ru) * 2002-01-15 2007-02-27 Актавис Груп Хф. Фармацевтический состав, содержащий хинаприл или фармацевтически приемлемую его соль
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
MX2019014201A (es) 2017-05-31 2020-01-23 Boehringer Ingelheim Int Composicion farmaceutica y forma de dosificacion farmaceutica que comprenden (e)-4-(2-(aminometil)-3-fluoroaliloxi)-n-ter-butilbenza mida, proceso para su preparacion, metodos de tratamiento y usos de las mismas.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
IL98934A0 (en) 1992-07-15
UA26064A1 (uk) 1999-04-30
HU222489B1 (hu) 2003-07-28
MY107183A (en) 1995-09-30
HU9102385D0 (en) 1991-12-30
AT400519B (de) 1996-01-25
CA2047802C (en) 2003-05-06
HUT59819A (en) 1992-07-28
CH683150A5 (de) 1994-01-31
AU639354B2 (en) 1993-07-22
PL291219A1 (en) 1992-08-24
DE4124409A1 (de) 1992-01-30
ATA147691A (de) 1995-06-15
ITRM910554A0 (it) 1991-07-23
JPH04253923A (ja) 1992-09-09
TW212757B (es) 1993-09-11
CA2047802A1 (en) 1992-01-26
DE4124409B4 (de) 2004-11-18
ZA915861B (en) 1993-03-31
FI913554A0 (fi) 1991-07-24
NZ239078A (en) 1993-10-26
ITRM910554A1 (it) 1993-01-23
RU2075310C1 (ru) 1997-03-20
IL98934A (en) 1996-07-23
FI913554A (fi) 1992-01-26
EP0468929B1 (en) 1994-09-28
SA92130106B1 (ar) 2005-10-16
KR100227156B1 (ko) 1999-10-15
PL167712B1 (en) 1995-10-31
EP0468929A3 (en) 1992-02-19
PT98417A (pt) 1992-06-30
KR920002146A (ko) 1992-02-28
DK0468929T3 (da) 1994-12-27
IT1290797B1 (it) 1998-12-11
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
ES2061218T3 (es) 1994-12-01
FI98127C (fi) 1997-04-25
CS230991A3 (en) 1992-04-15
CZ280184B6 (cs) 1995-11-15
IE66184B1 (en) 1995-12-13
NO912872D0 (no) 1991-07-23
AU8128691A (en) 1992-01-30
PT98417B (pt) 1999-01-29
FI98127B (fi) 1997-01-15
SK278563B6 (en) 1997-10-08
LU87980A1 (fr) 1993-02-15
IE912608A1 (en) 1992-01-29
EP0468929A2 (en) 1992-01-29
GB9115893D0 (en) 1991-09-04
JP2502849B2 (ja) 1996-05-29

Similar Documents

Publication Publication Date Title
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX9100031A (es) Compuestos de amino silicona y procedimiento para su preparacion
MX174176B (es) Compuestos azo y procedimiento para su preparacion
MX20476A (es) Composiciones de polipropileno y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9101034A (es) Mezclas y composiciones que contienen fenotiazinas y proceso para su preparacion
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX9100357A (es) Composiciones farmaceuticas estabilizadas y procedimiento para su preparacion
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX9100845A (es) Nuevas tienodiazepinas y procedimiento para su preparacion
MX9100742A (es) Composicion farmaceutica y procedimiento para su preparacion
MX9101516A (es) Derivados de 1,2,5,6-tetrahidropiridin 3-cetoxima y-3-aldoxina y procedimiento para su preparacion
MX9100743A (es) Compuestos heterociclicos y procedimiento para su preparacion
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9101081A (es) Compuestos fungicidamente activos y procedimiento para su preparacion
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX9205457A (es) Nuevos compuestos derivados de mupirocina y procedimiento para su preparacion
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
MX9101794A (es) Compuestos de trifendioxazina y procedimiento para su preparacion
DK0511991T3 (da) Farmaceutisk formulering
MX174317B (es) Procedimiento para la preparacion de 1-hidroximetilpirazoles